118 related articles for article (PubMed ID: 36451312)
1. Extracellular vesicle long RNA markers of early-stage lung adenocarcinoma.
Zhang Y; Liu W; Zhang H; Sun B; Chen T; Hu M; Zhou H; Cao Y; Han B; Wu L
Int J Cancer; 2023 Apr; 152(7):1490-1500. PubMed ID: 36451312
[TBL] [Abstract][Full Text] [Related]
2. Plasma extracellular vesicle microRNA profiling and the identification of a diagnostic signature for stage I lung adenocarcinoma.
Gao S; Guo W; Liu T; Liang N; Ma Q; Gao Y; Tan F; Xue Q; He J
Cancer Sci; 2022 Feb; 113(2):648-659. PubMed ID: 34837453
[TBL] [Abstract][Full Text] [Related]
3. Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for stage I lung adenocarcinoma.
Guo W; Huai Q; Liu T; Zhang G; Liang N; Ma Q; Liu X; Tan F; Xue Q; Gao S; Gao Y; He J
Transl Lung Cancer Res; 2022 Apr; 11(4):572-587. PubMed ID: 35529788
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
5. A panel of miRNAs derived from plasma extracellular vesicles as novel diagnostic biomarkers of lung adenocarcinoma.
Yao B; Qu S; Hu R; Gao W; Jin S; Liu M; Zhao Q
FEBS Open Bio; 2019 Dec; 9(12):2149-2158. PubMed ID: 31677346
[TBL] [Abstract][Full Text] [Related]
6. Identification and evaluation of circulating small extracellular vesicle microRNAs as diagnostic biomarkers for patients with indeterminate pulmonary nodules.
Zheng D; Zhu Y; Zhang J; Zhang W; Wang H; Chen H; Wu C; Ni J; Xu X; Nian B; Chen S; Wang B; Li X; Zhang Y; Zhang J; Zhong W; Xiong L; Li F; Zhang D; Xu J; Jiang G
J Nanobiotechnology; 2022 Apr; 20(1):172. PubMed ID: 35366907
[TBL] [Abstract][Full Text] [Related]
7. Secreted proteins MDK, WFDC2, and CXCL14 as candidate biomarkers for early diagnosis of lung adenocarcinoma.
Li J; Li J; Hao H; Lu F; Wang J; Ma M; Jia B; Zhuo M; Wang J; Chi Y; Zhai X; Wang Y; Wu M; An T; Zhao J; Yang F; Wang Z
BMC Cancer; 2023 Jan; 23(1):110. PubMed ID: 36721112
[TBL] [Abstract][Full Text] [Related]
8. Identification of theranostic factors for patients developing metastasis after surgery for early-stage lung adenocarcinoma.
Cheng WC; Chang CY; Lo CC; Hsieh CY; Kuo TT; Tseng GC; Wong SC; Chiang SF; Huang KC; Lai LC; Lu TP; Chao KSC; Sher YP
Theranostics; 2021; 11(8):3661-3675. PubMed ID: 33664854
[No Abstract] [Full Text] [Related]
9. Extracellular vesicle‑delivered miR‑505‑5p, as a diagnostic biomarker of early lung adenocarcinoma, inhibits cell apoptosis by targeting TP53AIP1.
Fang H; Liu Y; He Y; Jiang Y; Wei Y; Liu H; Gong Y; An G
Int J Oncol; 2019 May; 54(5):1821-1832. PubMed ID: 30864684
[TBL] [Abstract][Full Text] [Related]
10. Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA).
Liang W; Zhao Y; Huang W; Gao Y; Xu W; Tao J; Yang M; Li L; Ping W; Shen H; Fu X; Chen Z; Laird PW; Cai X; Fan JB; He J
Theranostics; 2019; 9(7):2056-2070. PubMed ID: 31037156
[No Abstract] [Full Text] [Related]
11. A novel microRNA signature for pathological grading in lung adenocarcinoma based on TCGA and GEO data.
Yang Z; Yin H; Shi L; Qian X
Int J Mol Med; 2020 May; 45(5):1397-1408. PubMed ID: 32323746
[TBL] [Abstract][Full Text] [Related]
12. Sensitive detection of stage I lung adenocarcinoma using plasma cell-free DNA breakpoint motif profiling.
Guo W; Chen X; Liu R; Liang N; Ma Q; Bao H; Xu X; Wu X; Yang S; Shao Y; Tan F; Xue Q; Gao S; He J
EBioMedicine; 2022 Jul; 81():104131. PubMed ID: 35780566
[TBL] [Abstract][Full Text] [Related]
13. Identification of seven-gene marker to predict the survival of patients with lung adenocarcinoma using integrated multi-omics data analysis.
Zhang S; Zeng X; Lin S; Liang M; Huang H
J Clin Lab Anal; 2022 Feb; 36(2):e24190. PubMed ID: 34951053
[TBL] [Abstract][Full Text] [Related]
14. A seven-long noncoding RNA signature predicts relapse in patients with early-stage lung adenocarcinoma.
Zhou H; Zhang H; Chen J; Cao J; Liu L; Guo C; Huang G; Zeng D
J Cell Biochem; 2019 Sep; 120(9):15730-15739. PubMed ID: 31050375
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment.
Wei T; Song J; Liang K; Li L; Mo X; Huang Z; Chen G; Mao N; Yang J
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1049-1064. PubMed ID: 33387038
[TBL] [Abstract][Full Text] [Related]
16. High-Throughput Peptide Arrays Identify Potential Diagnostic Autoantibody Signatures in Early-Stage Lung Adenocarcinoma.
Luo R; Zhong P; Li X; Cai J; Tao Y; Xiong B; Zheng H; Zhang Z; Tang L; Yao J; Li Y; Shi Y; Han X
Cancer Epidemiol Biomarkers Prev; 2023 May; 32(5):726-738. PubMed ID: 36857775
[TBL] [Abstract][Full Text] [Related]
17. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
[TBL] [Abstract][Full Text] [Related]
18. Genome‑wide investigation of the clinical significance and prospective molecular mechanisms of kinesin family member genes in patients with lung adenocarcinoma.
Zhang L; Zhu G; Wang X; Liao X; Huang R; Huang C; Huang P; Zhang J; Wang P
Oncol Rep; 2019 Sep; 42(3):1017-1034. PubMed ID: 31322267
[TBL] [Abstract][Full Text] [Related]
19. Identification of diagnostic DNA methylation biomarkers specific for early-stage lung adenocarcinoma.
Cai Q; Zhang P; He B; Zhao Z; Zhang Y; Peng X; Xie H; Wang X
Cancer Genet; 2020 Aug; 246-247():1-11. PubMed ID: 32805686
[TBL] [Abstract][Full Text] [Related]
20. Comparative Study of Autoantibody Responses between Lung Adenocarcinoma and Benign Pulmonary Nodules.
Wang J; Shivakumar S; Barker K; Tang Y; Wallstrom G; Park JG; Tsay JC; Pass HI; Rom WN; LaBaer J; Qiu J
J Thorac Oncol; 2016 Mar; 11(3):334-45. PubMed ID: 26896032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]